WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Green Eric Mark (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-23	Common Stock	A	2205.0000	$59.6400	Acquired	51118.7720	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-23	Stock Option (Right to Buy)	$59.6400	A	73724.0000	Acquired	2026-02-23	Common Stock (73724.0000)	Direct

Footnotes

F1: Bonus and incentive shares granted on 02/23/2016.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.